Bioavailability Study of Magne-B6 New Formulation

NCT06386211 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: MAGNE-B6 Oral Solution
DRUG: MAGNE-B6 New Formulation Tablet

Sponsor

Opella Healthcare Group SAS, a Sanofi Company